Effects of ribavirin on intrahepatic and
β
Dr. John Koskinas; Christopher Tibbs; Mohammed G. Saleh; Dr. Leila M. M. B. Pere
π
Article
π
1995
π
John Wiley and Sons
π
English
β 629 KB
## Abstract Response to ribavirin therapy (1,000β1,200 mg/day for 6 months) was evaluated in nine patients with chronic hepatitis C virus (HCV) infections who had previously failed to respond to a 6βmonth course of alphaβinterferon. All had chronic active hepatitis with elevated serum aminotransfer